Related Experiment Video
Updated: Mar 24, 2026
08:01
Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
8.4K
Ginger hexane extract suppresses RANKL-induced osteoclast differentiation
Suguru Ito1,2,3, Akihiro Ohmi2, Akiyo Sakamiya3
1a Tsuji Health & Beauty Science Laboratory , Mie University , Tsu, Japan.
Bioscience, Biotechnology, and Biochemistry
|March 12, 2016
Summary
Ginger hexane extract (GHE) inhibits osteoclast differentiation, offering potential for preventing and treating osteoporosis. GHE suppressed key genes involved in bone loss, suggesting a therapeutic role.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Osteoporosis is characterized by reduced bone density, increasing fracture risk.
- Anti-osteoclastic compounds are crucial for managing osteoporosis.
- Receptor activator of nuclear factor kappa-B ligand (RANKL) signaling drives osteoclast formation.
Purpose of the Study:
- To investigate the inhibitory effects of ginger hexane extract (GHE) on RANKL-induced osteoclastogenesis.
- To evaluate GHE's potential as a therapeutic agent for osteoporosis.
Main Methods:
- RAW264.7 cells were treated with GHE and stimulated with RANKL.
- Osteoclast differentiation, actin ring formation, and gene expression were assessed.
- Key osteoclastogenesis-related genes including Nfatc1, Oscar, Dc-stamp, Trap, and Mmp9 were analyzed.
Main Results:
- GHE significantly suppressed osteoclast differentiation and actin ring formation.
- GHE inhibited the expression of Nfatc1, a master regulator of osteoclastogenesis, in a dose-dependent manner.
- Expression of osteoclast-related genes (Oscar, Dc-stamp, Trap, Mmp9) was reduced by GHE.
Conclusions:
- Ginger hexane extract demonstrates potent anti-osteoclastic activity.
- GHE inhibits key molecular pathways essential for osteoclast differentiation.
- These findings support the potential of GHE for osteoporosis prevention and treatment.
